SpyGlass Pharma, Inc.

# SpyGlass Pharma, Inc.

SpyGlass Pharma develops and commercializes surgical and medical instruments, operating within the broader medical devices sector. The company is incorporated in Delaware and trades on the Nasdaq exchange with a market capitalization of approximately $0.9 billion.

The company's product portfolio centers on visualization and access devices designed for minimally invasive procedures. SpyGlass Pharma's primary offerings include instruments used in endoscopic and cholangioscopic applications, serving gastroenterology and related surgical specialties. These products enable physicians to visualize and treat conditions in the biliary and pancreatic systems.

Specific details regarding employee count, total revenue figures, and geographic distribution of operations are not available in the provided data. The company's classification within surgical and medical instruments reflects its positioning in the medical devices market rather than pharmaceutical manufacturing, despite the "Pharma" designation in its corporate name.